COVID-19 : NAFDAC approves clinical trials of Chloroquine in Lagos  The National Agency for Food and Drug Administration and Control ( NAFDAC ) has ordered the manufacturing of Chloroquine for an emergency stock for clinical treatment of Coronavirus .
The agency 's Director-General , Prof .
Mojisola Adeyeye said that the decision was made to toe the path of other countries that had adopted the drug for treating Covid-19 .
In an interview on Channels Television on Monday , Adeyeye noted that the clinical trials of the old antimalarial drugs would start in Lagos where the highest figures have been recorded so far .
" Lagos State will be starting a clinical trial on chloroquine to evaluate the effectiveness .
" Other researchers in France , the US have used the drug for the clinical trial treatment of COVID-19 and they reported the effectiveness of the drug , " she said .
She noted that China had demonstrations that showed chloroquine was effective in treating COVID-19 .
" In a very recent publication , chloroquine was reported in a press briefing by the State Council of China , indicating that chloroquine phosphate @ @ @ @ @ @ @ @ @ @ associated pneumonia in multi-centre clinical trials conducted in China .
She noted that chloroquine had been discontinued in Nigeria many years ago for use as anti-malarial because of parasitic resistance , but added that NAFDAC had approached a local manufacturer to make a batch of the drug .
" About four weeks ago , I approached a local manufacturing company ( May and Baker ) , a member of the Pharmaceutical Manufacturing Group of Manufacturing Association of Nigeria ( PMGMAN ) , whose flagship product in the past was chloroquine to make a batch of the drug for emergency stock .
" The company had NAFDAC approval for the production of the drug as antimalarial many years ago before the discontinuation , " she stated .
Regulatory activities of NAFDAC would be put in place to ensure that the clinical trial followed the laid-down protocol .
She observed that despite initial difficulties of the company to get the API since the production had been discontinued , they eventually got it and had manufactured a batch for the emergency stock , and was ready to make @ @ @ @ @ @ @ @ @ @ advised the public to desist from the use of Chloroquine without the guidance of a medical doctor or clinician for treatment of COVID-19 , noting that the drug has severe side effects including gastrointestinal upset , blurred vision , headache , and pruritis ( itching ) .
Related  Ruth Okwumbu has a MSc .
and BSc .
in Mass Communication from the University of Nigeria , Nsukka , and Delta state university respectively .
Prior to her role as analyst at Nairametrics , she had a progressive six year writing career .
As a Business Analyst with Narametrics , she focuses on profiles of top business executives , founders , startups and the drama surrounding their successes and challenges .
You may contact her via **28;2848;TOOLONG  Analysts have predicted the foreign reserves to fall below $30 billion if some measures are not taken .
ABOUT US  Nairametrics is a leading financial resource company based in Nigeria , with special focus on financial literacy , investor advocacy and business intelligence .
Nairametrics .
was founded by Ugochukwu " ugodre " Obi-chukwu and is owned by Nairametrics Financial Advocates Ltd .
